BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

59.07

-1.25 (-2.07%)

At close: Mar 12, 2026, 4:00 PM EDT

58.51

-0.56 (-0.95%)

After-hours: Mar 12, 2026, 4:56 PM EDT

BioMarin Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,221	2,854	2,419	2,096	1,846
Revenue Growth (YoY)	12.87%	17.97%	15.42%	13.53%	-0.76%
Cost of Revenue	717.44	580.24	532.06	503.02	470.52
Gross Profit	2,504	2,274	1,887	1,593	1,376
Selling, General & Admin	1,153	1,009	892.41	823.24	759.38
Depreciation & Amortization Expenses	19.39	43.26	62.21	67.19	69.93
Research & Development	921.93	747.18	746.77	649.61	628.79
Other Operating Expenses	-	-10	-	-108	-
Total Operating Expenses	2,094	1,789	1,701	1,432	1,458
Operating Income	409.48	484.21	185.77	160.97	-82.34
Interest Income	74.9	74.88	58.34	18.03	10.48
Interest Expense	-10.9	-12.67	-17.34	-15.97	-15.34
Other Non-Operating Income (Expense)	9	-4.67	-38.22	-13.46	11.85
Total Non-Operating Income (Expense)	73	57.55	2.79	-11.4	6.99
Pretax Income	482.48	541.76	188.56	149.58	-75.35
Provision for Income Taxes	133.58	114.9	20.92	8.02	-11.27
Net Income	348.9	426.86	167.65	141.56	-64.08
Net Income to Common	348.9	426.86	167.65	141.56	-64.08
Net Income Growth	-18.26%	154.62%	18.43%	-	-
Shares Outstanding (Basic)	192	190	188	185	183
Shares Outstanding (Diluted)	197	197	192	189	183
Shares Change (YoY)	0.35%	2.67%	1.39%	3.34%	-4.61%
EPS (Basic)	1.82	2.25	0.89	0.76	-0.35
EPS (Diluted)	1.80	2.21	0.87	0.75	-0.35
EPS Growth	-18.55%	154.02%	16.00%	-	-
Free Cash Flow	724.96	487.42	62.57	54.94	208.96
Free Cash Flow Growth	48.73%	679.02%	13.88%	-73.71%	-
Free Cash Flow Per Share	3.67	2.48	0.33	0.29	1.14
Gross Margin	77.73%	79.67%	78.01%	76.00%	74.52%
Operating Margin	12.71%	16.97%	7.68%	7.68%	-4.46%
Profit Margin	10.83%	14.96%	6.93%	6.75%	-3.47%
FCF Margin	22.51%	17.08%	2.59%	2.62%	11.32%
EBITDA	489.04	580.64	290.16	262.94	25.7
EBITDA Margin	15.18%	20.35%	11.99%	12.54%	1.39%
EBIT	409.48	484.21	185.77	160.97	-82.34
EBIT Margin	12.71%	16.97%	7.68%	7.68%	-4.46%
Effective Tax Rate	27.69%	21.21%	11.09%	5.36%	14.96%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q